跳至主導覽
跳至搜尋
跳過主要內容
長庚大學學術能量集萃 首頁
說明與常見問題
English
中文
首頁
學者概覽
研究單位
研究產出
研究計畫-專案
獎項
活動
新聞/媒體
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
王 齡玉
Ph.D.
副教授
,
生化學科
https://orcid.org/0000-0002-1413-817X
電子郵件
D000015328
cgu.edu
tw
h-index
h10-index
h5-index
1036
引文
14
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
439
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
65
引文
5
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2001
2025
每年研究產出
概覽
指紋
網絡
研究計畫-專案
(5)
研究產出
(25)
相近領域學者
(6)
指紋
查看啟用 Ling-Yu Wang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
100%
Cancer Cell
59%
Metabolic Pathway
50%
Nested Gene
39%
Kinase
33%
Long Noncoding RNA
28%
Stress
28%
Fission Yeast
28%
Histone
27%
Demethylase
26%
Regulatory Mechanism
22%
Growth
21%
Development
20%
Epigenetics
20%
Lysine
18%
Oncogene C Myc
18%
Mutation
17%
Protein Kinase
16%
Mitogen-Activated Protein Kinase
16%
Tyrosine
16%
Protein Catabolism
15%
Drug Resistance
15%
Association
15%
Relaxin
14%
Clostridium
14%
Non-Coding RNA
14%
Cell Membrane
14%
TRAIL
14%
RNA
14%
Germ Cell
14%
Tumor Gene
14%
EZH2
14%
Glycolysis
14%
Membrane Protein
14%
Pyruvate Kinase
14%
Pyruvate Dehydrogenase Kinase
14%
Autophagy
14%
Protein Hydrolysis
14%
Phosphorylation
14%
E2F1
14%
Metabolite
14%
Chimera
14%
Mitochondrial Respiration
14%
Src Family Kinase
14%
Catenin
14%
Androgen Receptor
14%
Gene Expression
12%
Genetics
11%
Alpha-Fetoprotein
9%
Staining
7%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen Receptor
62%
Prostate Cancer
60%
Castration Resistant Prostate Cancer
30%
Castration Resistant Prostate Cancer
28%
Malignant Neoplasm
20%
Cancer Growth
19%
Androgen
17%
Biological Marker
17%
Phosphotransferase Inhibitor
14%
Drug Resistance
14%
APC
14%
Polyglactin
14%
Protein Tyrosine Kinase
14%
Myricetin
14%
Untranslated RNA
14%
Liver Cancer
14%
Clostridium
14%
Natural Product
14%
Phosphotransferase
14%
Catenin
14%
RNA Directed RNA Polymerase Inhibitor
14%
Drug Discovery
14%
Androgen Receptor
10%
Enzalutamide
7%
Cell Cycle
7%
Anaphase Promoting Complex
7%
Carcinogenesis
6%
Small Interfering RNA
5%
Medicine and Dentistry
Combination Therapy
29%
Prostate Cancer
28%
Malignant Neoplasm
22%
Cancer Cell
18%
Biological Marker
17%
Therapeutic Procedure
16%
Diagnosis
14%
Protein Tyrosine Kinase
14%
Epigenomics
14%
Drug Resistance
14%
Untranslated RNA
14%
Neoplasm
14%
Liver Cancer
14%
Clustered Regularly Interspaced Short Palindromic Repeat
14%
Metabolism
14%
Autophagy
14%
Phosphotransferase Inhibitor
14%
Regulatory Mechanism
14%
Evaluation Study
14%
Castration Resistant Prostate Cancer
14%
Androgen Receptor
14%
Pandemic
14%
Programmed Cell Death
9%
Death Receptor
7%
Development
6%
Receptor Expression
6%
Receptor
5%
Chromatin
5%
Lung
5%
Gene
5%
Cells
5%
Tumor Cell
5%
